NL-OMON26108招募中不适用
Fecal microbiota tRAnspLantation uSed TO improve postpraNdial bacterIAl translocation; the RALSTONIA study
AMC-UvA0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Caucasian
排除标准
- •A history of cardiovascular event (CVA, MI or pacemaker implantation)
- •Use of any medication including PPI and antibiotics in the past three months
研究者
相似试验
已完成
不适用
Fecal microbiota tRAnspLantation uSed TO improve postpraNdial bacterIAl translocation;<br>the RALSTONIA study.metabolic syndrome10018424insulin resistanceNL-OMON47262Academisch Medisch Centrum36
招募中
不适用
Fecal microbiota transplantation for improved Fructose catabolism and Insulin sensiTivity In patients with metabolic syndrome : the FFIT study10018424insulin resistance/Dm2microbiotaNL-OMON49935Academisch Medisch Centrum56
招募中
不适用
Fecal microbiota transplantation for improved Fructose catabolism and Insulin sensiTivity In patients with metabolic syndromemetabolic syndrome, insuline resistanceNL-OMON24239Amsterdam UMC48
已完成
不适用
A study of usefulness of fecal microbiota transplantation for refractory Clostridium difficile infectioJPRN-UMIN000018731agoya University Graduate School of Medicine, Department of Gastroentrology and hepatology10
招募中
不适用
Effects of drug (Tenofovir, FMT, Plasma Exchange therapy) in Liver Disease (ACLF-HBV).CTRI/2020/06/026062Institute of Liver and Biliary Sciences